Back to Search Start Over

Esophageal plexiform fibromyxoma: A case report with molecular analysis for MALAT1-GLI1 fusion.

Authors :
Higashi M
Hamada T
Sasaki K
Tsuruda Y
Shimonosono M
Kitazono I
Kirishima M
Tasaki T
Noguchi H
Tabata K
Hisaoka M
Fukukura Y
Ohtsuka T
Tanimoto A
Source :
Pathology, research and practice [Pathol Res Pract] 2022 May; Vol. 233, pp. 153878. Date of Electronic Publication: 2022 Apr 04.
Publication Year :
2022

Abstract

Plexiform fibromyxoma (PFM) is a rare gastrointestinal tract tumor that develops in the stomach in most cases. Here, we report an extremely rare case of esophageal PFM. A female in her mid-30 s presented with difficulty in swallowing and breathing. Endoscopic examination revealed a submucosal tumor measuring approximately 45 × 50 mm in the upper thoracic esophagus. The biopsied specimen did not show definite histological evidence of gastrointestinal stromal tumors (GISTs). Since imatinib administration based on a clinical diagnosis of GIST did not show a therapeutic effect for tumor reduction, tumor resection was performed. The resected tumor exhibited proliferation of spindle tumor cells with abundant myxoid and vascular stroma separated by a muscular layer, indicating a plexiform arrangement. Immunohistochemical analysis demonstrated that the tumor cells diffusely expressed vimentin and alpha-smooth muscle actin, but not desmin, c-kit, DOG1, and CD34. MALAT1-GLI1 fusion was detected in formalin-fixed paraffin-embedded tissue using RT-PCR and Sanger sequencing. The results suggested that a fibromyxoid tumor can develop in the esophagus, showing an identical histology and MALAT1-GLI1 fusion to gastric PFM.<br /> (Copyright © 2022 Elsevier GmbH. All rights reserved.)

Details

Language :
English
ISSN :
1618-0631
Volume :
233
Database :
MEDLINE
Journal :
Pathology, research and practice
Publication Type :
Academic Journal
Accession number :
35397317
Full Text :
https://doi.org/10.1016/j.prp.2022.153878